For the quarter ending 2025-09-30, CDXS had -$1,427K decrease in cash & cash equivalents over the period. -$7,885K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -19,615 | -33,960 |
| Depreciation and amortization | 1,356 | 2,535 |
| Reduction in the carrying amount of right-of-use assets | 738 | 1,440 |
| Stock-based compensation | 2,513 | 4,911 |
| Provision (recovery) for credit losses | 0 | -113 |
| Asset impairment and other charges | 0 | 0 |
| Impairment of investment in non-marketable securities | 0 | - |
| Non-cash interest expense | 357 | 572 |
| Amortization of discount on short-term investments | -334 | -597 |
| Other non-cash items | 0 | 0 |
| Financial assets | -6,706 | -2,640 |
| Inventories | -9 | 146 |
| Prepaid expenses and other assets | 1,725 | -405 |
| Accounts payable | 905 | -1,398 |
| Accrued compensation and other accrued liabilities | -1,983 | 6,278 |
| Other long term liabilities | -792 | -1,526 |
| Deferred revenue | 196 | -250 |
| Net cash used in operating activities | -7,703 | -31,765 |
| Purchase of property and equipment | 182 | 3,769 |
| Proceeds from sale of property and equipment | 1 | 4 |
| Purchases of short-term investments | 17,708 | 24,183 |
| Proceeds from maturity of short-term investments | 24,276 | 39,350 |
| Proceeds from sale of short-term investments | 0 | - |
| Net cash provided by (used in) investing activities | 6,387 | 11,402 |
| Proceeds from exercises of stock options | 0 | 1,098 |
| Proceeds from issuance of stock under employee stock purchase plan | 0 | 317 |
| Proceeds from issuance of common stock in connection with equity sales agreements | 0 | 17,268 |
| Costs incurred in connection with equity sales agreements | 111 | 718 |
| Proceeds from long-term debt | 0 | 9,897 |
| Payment of debt issuance costs | 0 | 3 |
| Net cash provided by financing activities | -111 | 27,859 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -1,427 | 7,496 |
| Cash and cash equivalents at beginning of period | 20,829 | - |
| Cash and cash equivalents at end of period | 26,898 | - |
CODEXIS, INC. (CDXS)
CODEXIS, INC. (CDXS)